Sunitinib in Combination with Erlotinib for the Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Thongprasert, Sumitra [1 ]
Govindan, Ramaswamy [2 ]
Krzakowski, Maciej
Szczesna, Aleksandra
Strausz, Janos [3 ]
Makhson, Anatoly [4 ]
Tye, Lesley
Zhang, Ke
Chao, Richard C.
Scagliotti, Giorgio V. [5 ]
机构：
[1] Chiang Mai Univ, Dept Med, Chiang Mai, Thailand
[2] Washington Univ, Sch Med, Dept Oncol, St Louis, MO 63130 USA
[3] Koranyi Natl Inst Pulmonol, Dept Bronchol, Budapest, Hungary
[4] Moscow City Clin Hosp Oncol, Dept Chemotherapy, Moscow, Russia
[5] Univ Turin, Dept Clin & Biol Sci, I-10124 Turin, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S375 / S375
页数：1
相关论文
共 50 条
  • [1] Sunitinib in Combination With Erlotinib for the Treatment of Advanced/Metastatic Non-small Cell Lung Cancer (NSCLC): a Phase III Study
    Govindan, R.
    Krzakowski, M. J.
    Szczesna, A.
    Strausz, J.
    Makhson, A. N.
    Reck, M.
    Tye, L.
    Zhang, K.
    Chao, R. C.
    Scagliotti, G. V.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S557 - S557
  • [2] SUNITINIB (SU) IN COMBINATION WITH ERLOTINIB (E) FOR THE TREATMENT OF ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC): A PHASE III STUDY
    Scagliotti, G. V.
    Krzakowski, M.
    Szczesna, A.
    Strausz, J.
    Makhson, A.
    Reck, M.
    Tye, L.
    Selaru, P.
    Chao, R. C.
    Govindan, R.
    ANNALS OF ONCOLOGY, 2010, 21 : 3 - 4
  • [3] ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT
    Goncalves, Ivone M.
    Monteiro, Regina
    Neves, Sofia
    Conde, Sara
    Campainha, Sergio
    Parente, Barbara
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1298 - S1298
  • [4] EXPERIENCE OF USING ERLOTINIB FOR TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Kanazawa, Kenya
    Ishida, Takashi
    Suzuki, Aya
    Tachihara, Motoko
    Minemura, Hiroyuki
    Sekine, Satoko
    Oshima, Kengo
    Yokouchi, Hiroshi
    Watanabe, Kana
    Tanino, Yoshinori
    Munakata, Mitsuru
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1310 - S1310
  • [5] Cutaneous toxicity in erlotinib treatment for advanced non-small cell lung cancer (NSCLC)
    Bernabee, R.
    Cobo, M.
    Barneto, I.
    Valdivia, J.
    Fernandez, I.
    Rueda, A.
    Villatoro, R.
    de la Curz, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Phase II study of erlotinib (E) with or without sunitinib (SU) in the treatment of metastatic non-small cell lung cancer (NSCLC)
    Blumenschein, G. R., Jr.
    Robert, F.
    Melnyk, O.
    Sutherland, K. C.
    Tye, L.
    Wang, E.
    Chao, R.
    Fossella, F.
    EJC SUPPLEMENTS, 2007, 5 (04): : 360 - 360
  • [7] Approval Summary: Erlotinib Maintenance Therapy of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
    Cohen, Martin H.
    Johnson, John R.
    Chattopadhyay, Somesh
    Tang, Shenghui
    Justice, Robert
    Sridhara, Rajeshwari
    Pazdur, Richard
    ONCOLOGIST, 2010, 15 (12): : 1344 - 1351
  • [8] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
    Shao, Yu-Yun
    Lin, Chia-Chi
    Yang, Chih-Hsin
    DISCOVERY MEDICINE, 2010, 9 (49) : 538 - 545
  • [9] Review of erlotinib in the treatment of advanced non-small cell lung cancer
    Ganjoo, Kristen N.
    Wakelee, Heather
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (04): : 335 - 346
  • [10] Sorafenib and sunitinib in the treatment of advanced non-small cell lung cancer
    Gridelli, Cesare
    Maione, Paolo
    Del Gaizo, Filomena
    Colantuoni, Giuseppe
    Guerriero, Ciro
    Ferrara, Carmine
    Nicolella, Dario
    Comunale, Daniela
    De Vita, Alba
    Rossi, Antonio
    ONCOLOGIST, 2007, 12 (02): : 191 - 200
12345